PubMed · 854449
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
J D Gaskell. 1977-04-14. Try a lemon.. https://pubmed.ncbi.nlm.nih.gov/854449/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The effect of the removal of the smear layer on coronal leakage of root fillings was studied using two sealer cements. Sixty single-rooted teeth with mature apices were prepared chemomechanically using a modified double-flared technique with non-cutting tipped files and copious irrigation with 2% sodium hypochlorite. The teeth were randomly allocated to four groups of 15 teeth each. Two groups were treated with 40% citric acid to remove the smear layer. Two groups of teeth, one with and one without smear layer, were filled by lateral condensation of gutta-percha with either Tubliseal or a resin-based glass ionomer, Vitrebond. The teeth were stored for 1 week, thermocycled, and the extent of coronal leakage determined for each group after immersion in Indian ink for 90 h. The teeth were demineralized, dehydrated and immersed in methyl salicylate which rendered them transparent. Linear measurement of dye penetration was recorded. The mean depth (+/- SD) of leakage for the groups in which the smear layer was left intact was 4.26 +/- 1.53 mm and 6.83 +/- 1.65 mm for the Vitrebond and Tubliseal, respectively. When the smear layer had been removed, the mean depth of leakage for the Vitrebond group was 1.13 +/- 0.29 mm, and 3.72 +/- 1.23 mm for the Tubliseal group. There was a statistically significant difference in leakage between the groups (P < 0.001). With both sealers, those teeth in which the smear layer had been removed showed less leakage than the specimens in which the smear layer was left intact (P < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
Explore the source record for details and available documents.
Citrate is recognized as one of the inhibitors of urinary stone formation. If the urinary citrate and pH could be elevated by the supply of potassium citrate, the recurrence of stone formation would hopefully be prevented. Urocit-K is a kind of slow releasing preparation of potassium citrate. The pharmacokinetics of Urocit-K is investigated in this study, which included two groups: 1) the hypocitraturia group consisting of twenty patients and 2) the normal volunteer group consisting of ten persons. Urokit-K was administered to patients in 10 mEq doses, t.i.d. for 2 weeks. Comparison of urinary biochemistry was done prior to, and one week after administration of the Urocit-K. In the normal volunteer group, the pharmacokinetics of Urocit-K was determined by urinary pH, K, and citrate. Determinations were made six times a day (every 2-hours for first 8 hours, 7- and 9- hours for the last 16 hours) with Urocit-K for comparison. This study indicated that Urocit-K increases urinary pH, K, and citrate in hypocitraturic patients. In the normal volunteer group, Urocit-K deserves its slow-releasing property shown by a constant increase of urinary pH and K for the first 8 hours; and urinary citrate for almost 24 hours. No apparent complications, such as gastrointestinal upset or cardiopulmonary discomfort were observed. In conclusion, Urocit-K is an excellent preparation of potassium citrate and a good choice for prevention of stone recurrence.